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Abstract
Ageing involves a progressive decline of the body’s regulatory systems including immune system. Adenosine
regulates immune function by interaction with its receptors, mainly adenosine A2A receptor, present on the surface
of immune cells. Furthermore, cellular response to this nucleoside is highly dependent on its extracellular
concentration that is regulated by ecto-enzymes such as CD39 and CD73. Therefore, the aim of this study was to
investigate the effect of age on adenosine A2A receptor, CD39 and CD73 gene expression. Changes in mRNA were
measured by quantitative PCR from peripheral blood of young, middle-aged and older adults as well as
centenarians. Centenarians showed a prominent decrease of CD39 and CD73 mRNA in comparison with older
adults. Regarding to adenosine A2A receptor, we detected two subgroups of centenarians with high and low level
of transcript. Additionally, adenosine A2A receptor mRNA level of centenarians, did not correlate with their
cognitive impairment. In summary, our pilot study suggests that unlike of adenosine A2A receptor, the level of
CD39 as well as CD73 mRNA could be a hallmark of successful human ageing.
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Introduction
Immunosenescence, the age-related decline in immune
response, increases morbidity and mortality in the eld-
erly population [1]. Therefore, the preservation of im-
mune function is a marker of longevity. Indeed, the
function of innate and adaptive immunity cells is not
impaired in centenarians, example of extreme longevity
and compression of morbidity [2, 3].
Adenosine regulates immune function by interaction
with its receptors, mainly adenosine A2A receptor
(ADORA2A), present on the surface of immune cells [4].
This nucleoside is generated from extracellular nucleo-
tides by ecto-enzymes such as CD39 and CD73 that are
expressed by immune cells [4]. Consequently, these pro-
teins, can also regulate immune function [5].
Whereas these previous studies showed the key role of
adenosinergic system in immune regulation, they pro-
vided little information about the age-related changes of
this system [4, 5]. Therefore, and since immune response
is crucial to a healthy ageing, we have investigated the
effect of age on CD39, CD73 and ADORA2A mRNA ex-
pression in blood cells of young, middle-aged and older
adults as well as centenarians.
Material and methods
Subjects and samples
A total of fifty-seven healthy subjects from Spain were
included in the analysis. We used peripheral blood of 13
young adults (median age: 23, 8 males and 5 females), 12
middle-aged adults (median age: 45, 6 males and 6 fe-
males), 11 older adults (median age: 79, 3 males and 8
females) and 21 centenarians (median age: 102, 4 males
and 17 females).
Individuals with autoimmune diseases or similar; in-
flammation; malignancy; malnutrition (Quetelet index <
20 for females and 22 for males); alcoholism and demen-
tia (when it eliminates his consent capability) were ex-
cluded. It was evaluated the physical (by modified
Barthel index [6]) and mental health (by Spanish version
of the Pfeiffer’s test [7]) statuses of older adults as well
as centenarians (see Additional file 1).
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Peripheral blood samples were collected in BD Vacu-
tainer EDTA tube (BD Biosciences, New Jersey, USA) al-
ways in the morning. Blood aliquots were frozen and
stored at – 80 °C until total RNA isolation.
RNA isolation, cDNA synthesis and quantitative PCR
Total RNA was isolated from blood aliquots using
NucleoSpin RNA Blood Kit (Macherey-Nagel, Düren,
Germany), following the manufacturer’s instructions.
First-strand cDNA synthesis was performed from 33 μl
of total RNA, using High Capacity cDNA Reverse Tran-
scription Kit and random hexamer primers (Life Tech-
nologies, Madrid, Spain). Quantitative PCR (qPCR) was
performed in triplicate using cDNA, the Quantitect
SYBR Green Kit (Qiagen, Madrid, Spain) and gene-
specific PCR primers for CD39 (QT00094787, Qiagen),
CD73 (QT02451512, Qiagen) as well as ADORA2A (5′-
GGATGTGGTCCCCATGAACTA-3′/5′-CCAGGAAGA
TCCGCAAATAGAC-3′), on an ABI Prism 7300 PCR
System (Life Technologies). The thermal cycler program
was 15 min at 95 °C, followed by 40 cycles of 15 s at
94 °C, 30 s at 55 °C and 34 s at 72 °C (data collection
step). Non-template and non-reverse transcribed con-
trols were included in all experiments. Analysis of the
melting curves confirmed the specificity of PCR and the
absence of primer-dimers.
β-actin gene (ACTB) (HK-SY-hu-600, PrimerDesign,
Southampton, UK) was used as internal control to
normalize mRNA relative expression, after its validation
for qPCR. Validation of the internal control gene and
qPCR data analysis were performed by 2-ΔCt and 2-ΔΔCt
method, respectively, once confirmed that the amplifica-
tion efficiency of all primers pairs were similar and close
to a value of 2 (Additional file 1).
Statistical analysis
GraphPad Prism 6.0 (GraphPad Software, San Diego,
USA) was used for statistical analyses, and the tests used
are given in the corresponding figure legends. The ad-
equacy of sample size was tested using the statistical
software Granmo 6.0 (Institut Municipal d’Investigació
Médica, Barcelona, Spain) with an accepted two-sided
alpha risk of 0.05 and a beta risk of 0.20.
More information in Additional file 1.
Results
We examined the mRNA level of CD39, CD73 and
ADORA2A by qPCR, using ACTB gene to normalize
because its expression was unaffected by age (p = 0.7627)
(Additional file 2: Figure S1).
In our study, young and middle-aged individuals pre-
sented a similar pattern of expression for all genes (p >
0.05) (Figs. 1 and 2a).
We have found that centenarians have a comparable
level of CD39 mRNA (p > 0.05) and a lower level of
CD73 mRNA (2.3-fold lower) than young adults (Fig. 1).
Conversely, older adults showed a marked overexpres-
sion of CD39 (3.1-fold vs. young and 4.4-fold vs. cente-
narians) and CD73 (3.8-fold vs. young and 8.8-fold vs.
centenarians) genes (Fig. 1). Likewise, we observed
ADORA2A gene overexpression in older adults vs.
young adults (2.6-fold) and centenarians (1.5-fold)
(Fig. 2a).
Due to the abnormal error bar of centenarians group
(Fig. 2a), we analyzed the level of ADORA2A mRNA in
each centenarian sample and detected two subpopula-
tions: one with a high level of transcript (so-called “over-
expressed” centenarians) and other with a low level of
transcript (so-called “underexpressed” centenarians)
(Fig. 2b). Overexpressed centenarians presented higher
ADORA2A mRNA level than young (4.6-fold) and simi-
lar level to older adults (p = 0.5804) (Fig. 2). Conversely,
underexpressed centenarians showed a low level of
ADORA2A transcript in comparison with young (1.5-
fold lower) and older adults (4.4-fold lower) (Fig. 2).
Nevertheless, the difference with young group is statisti-
cally inconclusive due to the sample size.
Finally, we also studied individual characteristics in-
cluding presence or type of chronic disease, commonly
used drugs, gender, the level of physical function and
cognitive impairment, in the two subgroups of centenar-
ians. We found only differences, but not statistically sig-
nificant, in the number of individuals with mild and
moderate impairment (p = 0.073) (Table 1).
Discussion
Ageing involves a progressive decline of the immune
system [8]. Since adenosine is essential for immune
function [4] we have investigated the effect of age on
CD39 and CD73, as well as ADORA2A mRNA expres-
sion in human blood cells [9, 10].
Our results show lower expression of CD39 and CD73
genes in centenarians than older adults. In Spain, only
4% of people aged 70 will be centenarians (data obtained
from 1996 and 2016 census of the National Statistics In-
stitute, Spanish Statistical Office). Since centenarians are
an example of compression of morbidity and extreme
longevity, underexpression of these genes might be an
important factor to successful ageing [11]. Indeed, cente-
narians present immune cells with a similar activity to
those of young people [2, 3, 12]. These immunological cir-
cumstances might explain, at least in part, why centenar-
ians can keep out infections and thus prolong their life.
Age-associated changes of immune cells at the mo-
lecular level have also been studied. So, Serna and col-
leagues demonstrated a similar pattern of mononuclear
cells small non-coding RNAs expression between
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centenarians and young people whereas that of octoge-
narians was radically different [13]. Additionally, Fann
and coworkers analyzed the gene-expression profiles of
human memory CD8+ T cells and found changes in the
expression of several cell-surface receptors such as
CD28 with age [14]. More recently, Fang and colleagues
have found CD39 overexpression in stimulated T cells of
older individuals [15]. These authors demonstrate that
the age-mediated induction of CD39 mRNA and its cog-
nate protein evoke T cell apoptosis and thus, prevents
the generation of memory T cells after vaccination [15].
Indeed, CD39 cleaves ATP to ADP and AMP that via P2
purinergic receptors may control cellular immune re-
sponse. CD73 degrades AMP to adenosine that also me-
diate purinergic effects via its P1 receptors [10].
Mackiewicz and colleagues observed a higher CD73 ac-
tivity in the brain of older rats than in young animals
[16]. Additionally, several studies have demonstrated
that CD73 is overexpressed in cancer, a disease that pre-
dominantly affects older individuals [17, 18].
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Fig. 1 Effect of ageing on CD39 and CD73 gene expression in human peripheral blood cells. Quantification of CD39 (a) and CD73 (b) mRNA fold
change in cells of young, middle-aged and older adults as well as centenarians. Gene expression level data for each gene and sample
were normalized to ACTB signal (internal control) and relative to the mean normalized value of CD39/CD73 gene expression in young
adults group. Error bars represent S.E.M. of the means obtained in each group (n = 13 per young adults and centenarians; n = 12 per
middle-aged adults and n = 11 per older adults group). a: *** indicates statistically significant differences (p < 0.001) between older adults
and the rest of groups. b: **** denotes highly significant differences (p < 0.0001) between older adults and the rest of groups; # # and # # # mean
significant differences (p < 0.01 and p < 0.001, respectively) between groups linked by horizontal square brackets. The p values were determined by
Mann–Whitney test
0
1
2
3
4
6
8
ba
¤¤¤¤ 
Young adults Middle-aged adults Older adults Centenarians
Overexpressed
Underexpressed
Fig. 2 Effect of ageing on ADORA2A gene expression in human peripheral blood cells. a Quantification of ADORA2A mRNA fold change in cells
of young, middle-aged and older adults as well as centenarians. ADORA2A mRNA level for each sample was normalized to ACTB signal (internal
control) and relative to the mean normalized value of ADORA2A gene expression in young adults group. Error bars represent S.E.M. of the means
obtained in each group (n = 13 per young adults; n = 12 per middle-aged adults; n = 11 per older adults; n = 21 per centenarian group). ** (p <
0.01) and **** (p < 0.0001) indicate statistically significant differences between older adults and the rest of groups. b ADORA2A mRNA fold change
in different subgroups of a centenarians. ¤ ¤ ¤ ¤ (p < 0.0001) indicates significant differences between centenarian’s subgroups, overexpressed (n = 7)
and underexpressed (n = 14). # # # (p < 0.001) and # # # # (p < 0.0001) denote highly significant differences between the subgroup of overexpressed
centenarians and young as well as middle-aged adults groups of a, respectively. ♦ (p < 0.05) and ♦ ♦ ♦ ♦ (p < 0.0001) mean statistical differences between
the subgroup of underexpressed centenarians and the rest of groups of a. The p values were determined by Mann–Whitney test
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Our qPCR results also demonstrate CD73 underexpres-
sion in centenarians versus young adults. Previous studies
have found a decline of centenarians CD28+CD8+ T cells
when compared with those of young people [19, 20].
CD73 is expressed on the surface of CD8+ T lymphocytes
and therefore, the smaller number of these cells in cente-
narians might explain why they underexpress CD73
[21, 22]. Additionally and since centenarians present a
greater number of CD28+CD8+ T cells than octoge-
narians, the differences of expression between these
last groups could be larger than those observed [19].
Regarding ADORA2A, our results show that older
adults present a higher level of ADORA2A transcript
than young adults and centenarians. Again, high ex-
pression of this gene seems to be a handicap to a
healthy ageing. In fact, overexpression of ADORA2A
mediate the susceptibility to apoptosis of older CD39+
T cells [15].
Nonetheless, differences between older adults and cen-
tenarians are lesser than those for CD39/CD73. Indeed,
centenarians present higher but not significant
ADORA2A expression than young adults. These results
can be explained by the existence of two subpopulations
of centenarians characterized by high and low level of
ADORA2A mRNA. Consequently, the level of
ADORA2A mRNA could not be a critical factor for suc-
cessful ageing.
Evidence of the existence of different centenarian sub-
populations has been previously reported [23]. This
work defined two subgroups of centenarians with high
and low values of basic immune parameters [23]. On the
other hand, the group of Bergamaschini detected differ-
ent levels of ADORA2A mRNA and its cognate receptor
in patients with diverse grade of cognitive impairment
[24]. Our statistical analysis on mental damage in both
centenarian subgroups indicates, that their grade of cog-
nitive impairment, is independent of ADORA2A mRNA
levels.
It must be stated that this is a preliminary study and
more research is needed to confirm our results. We
propose to investigate the relationship between mRNA
and protein expression, particularly in the case of
ADORA2A. Additionally, an excellent subject of study is
the possible correlation of our gene expression findings
with the number and type of immune cells. The study of
centenarian offspring is currently a focus of attention for
much longevity research [25]. In fact, Van den Berg and
colleagues have recently demonstrated that individuals
with a familial predisposition for longevity present a
high-amplitude rhythm of serum cholesterol concentra-
tion [26]. In this context, numerous studies have pro-
vided the connection between circadian rhythms and the
immune system [27, 28]. Therefore, we think that it
would be very interesting to carry out this same study in
centenarian’s offspring.
Conclusions
Our analysis of peripheral blood gene expression dem-
onstrated a significantly lower level of CD39 and CD73
mRNA in centenarians than older adults. Consequently,
we suggest that the level of CD39 as well as CD73
mRNA could be a hallmark of successful human ageing.
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Table 1 Proportion of cognitive impairment in centenarian subgroups
Mental status Overexpressed, % (n) Underexpressed, % (n)
Intact intellectual functioning (0–2 errors) 14.3 (1) 38.5 (5)
Mild intellectual impairment (3–4 errors) 0.0 (0) 23.1 (3)
Moderate intellectual impairment (5–7 errors) 57.1 (4) 7.7 (1)
Severe intellectual impairment (8–10 errors) 28.6 (2) 30.8 (4)
Mental status was determined by the Spanish version of the Pfeiffer’s test [7]. p = 0.073, Chi-square test
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